BioCentury
ARTICLE | Clinical News

Secnidazole: Phase I data

March 16, 2015 7:00 AM UTC

An open-label Phase I trial in 54 healthy female volunteers showed that co-administration of a single dose of 2 g oral SYM-1219 a single dose of an ethinyl estradiol/norethindrone combination birth co...